A straightforward method to quantify circulating mRNAs as biomarkers of colorectal cancer - Institut de Recherche en Cancérologie de Montpellier Access content directly
Journal Articles Scientific Reports Year : 2023

A straightforward method to quantify circulating mRNAs as biomarkers of colorectal cancer

Abstract

Abstract Optimizing the biomarker combination to be analyzed in liquid biopsies should improve personalized medicine. We developed a method to purify circulating cell-free mRNAs from plasma samples and to quantify them by RT-qPCR. We selected three candidate colorectal cancer biomarkers ( B2M , TIMP-1 , and CLU ). Their mRNA levels were significantly higher in plasma of patients with metastatic colorectal cancer patients (mCRC) (n = 107) than in healthy individuals (HI) (n = 53). To increase the discriminating performance of our method, we analyzed the sum of the three mRNA levels (BTC index). The area under the ROC curve (AUC) to estimate the BTC index capacity to discriminate between mCRC and HI plasma was 0.903. We also determined the optimal BTC index cut-off to distinguish between plasma samples, with 82% of sensitivity and 93% of specificity. By using mRNA as a novel liquid biopsy analytical parameter, our method has the potential to facilitate rapid screening of CRCm.
Fichier principal
Vignette du fichier
41598_2023_Article_29948.pdf (1.18 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive
licence : CC BY - Attribution

Dates and versions

hal-04002748 , version 1 (02-06-2023)

Licence

Attribution

Identifiers

Cite

Marie Grosgeorges, Laurence Picque Lasorsa, Brice Pastor, Corinne Prévostel, Evelyne Crapez, et al.. A straightforward method to quantify circulating mRNAs as biomarkers of colorectal cancer. Scientific Reports, 2023, 13 (1), pp.2739. ⟨10.1038/s41598-023-29948-4⟩. ⟨hal-04002748⟩
25 View
10 Download

Altmetric

Share

Gmail Facebook X LinkedIn More